These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 25245997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM, Martell CW.
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
    Graziottin A.
    Eur J Contracept Reprod Health Care; 2016 Jan; 21(2):93-105. PubMed ID: 26291185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
    Caruso S, Agnello C, Romano M, Cianci S, Lo Presti L, Malandrino C, Cianci A.
    J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
    Micks E, Jensen JT.
    Womens Health (Lond); 2011 Sep; 7(5):513-24. PubMed ID: 21879819
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A.
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [Abstract] [Full Text] [Related]

  • 13. Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under.
    Jensen JT, Bitzer J, Nappi RE, Ahlers C, Bannemerschult R, Parke S.
    Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):98-105. PubMed ID: 32162555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011 Apr; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 20. Quadriphasic versus monophasic oral contraceptives for contraception.
    Van Vliet HA, Raps M, Lopez LM, Helmerhorst FM.
    Cochrane Database Syst Rev; 2011 Nov 09; (11):CD009038. PubMed ID: 22071862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.